Apollomics, Inc. (APLM) vs eXoZymes, Inc. (EXOZ)
A side-by-side comparison of Apollomics, Inc. and eXoZymes, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$23.40HealthcareDelayed quote: Oct 6, 2026, 11:29 AM EDT
EXOZ
eXoZymes, Inc.
$5.60HealthcareDelayed quote: Oct 6, 2026, 11:28 AM EDT
Total return — APLM vs EXOZ
growth of $100 · dividends reinvested · last 2yAPLM +94.4% (+39.4%/yr)EXOZ -36.2% (-20.1%/yr)APLM compounded faster over this window
APLM EXOZ
APLM vs EXOZ: by the numbers
- •EXOZ is the larger company ($52M vs $51M market cap).
- •Both run net losses; EXOZ's is the smaller (0.00% vs -128.69% net margin).
Metrics side by side
Valuation
| Metric | APLM | EXOZ |
|---|---|---|
| P/B ratio | N/A | 14.22 |
Profitability
| Metric | APLM | EXOZ |
|---|---|---|
| Gross margin | 97.00% | 0.00% |
| Operating margin | -111.45% | 0.00% |
| Net margin | -128.69% | 0.00% |
| ROE | N/A | -278.89% |
| ROIC | -2441.49% | -157.40% |
Growth (annualized)
| Metric | APLM | EXOZ |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | N/A |
Go deeper
Dig into the metrics
Apollomics ROEeXoZymes ROEApollomics operating margineXoZymes operating marginApollomics revenue growtheXoZymes revenue growthApollomics free cash floweXoZymes free cash flow
Apollomics & eXoZymes appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.